Behind the Luck.
Release time:
2020-08-14
"Luck"
Artificial Bezoar Workshop Reconstruction Documentary
After four months of intense work, 8# September 9 , the artificial bezoar technical renovation project of Qiubin Factory was successfully completed, 8 18 , 19 , 20 , the trial production of the first three batches of products was successfully completed. Yi Shengrong, director of the Akihama Factory, lamented, "We are lucky this time".
Good luck, this is of course a joke. To do such a big project well, luck alone is of course not enough. What really plays a decisive role is the seriousness and hard work of the project team members.
Pharmaceutical Company has many years of successful experience in producing artificial bezoar, but from the beginning of the project transformation, due to the use of raw materials, production process, process standards, and production scale are almost different, so the previous experience is not for them. Help, can only be explored from scratch through the efforts of participating construction personnel. From the beginning of the
project, the project team was formed by Yi Shengrong, director of Qiubin Factory, Yu Chengfeng, production technology department, Yan Xixia, workshop director, Fang Weiming, mechanic, and Tang Songnian, electrician. While ensuring normal production, the project began to transform. The civil engineering project of workshop
started in March 4 . The project team members divided their work according to their own fields. Fang Weiming and Tang Songnian, who were responsible for equipment selection, went to many equipment manufacturers to understand relevant information, make comparisons and prepare for bidding. Compared with the previous production, the requirements for environmental protection are higher now. When designing the artificial bezoar workshop, it was decided to adopt dust-free transportation. All equipment is connected through pipelines. In order to meet this requirement, most equipment must be customized from the manufacturer. Before the formal bidding of the equipment, the project team also held a special meeting to brainstorm and put forward opinions and suggestions on equipment selection according to the collected information and their own work experience. It has been suggested that corn starch is one of the main raw materials for the production of artificial bezoar. A lot of heat will be generated during the ball milling process. If the temperature is too high, the starch will stick together and affect the quality of the product. Although there is no requirement for this in the process standard, it can be related to the quality of the product, so when selecting the equipment, the equipment manufacturer is required to increase the cooling system for the heat dissipation problem of the ball mill. Fang Weiming said that it takes three months for general equipment manufacturers to obtain orders and provide products, but we only have more than one month, and the equipment is not stereotyped, so the two sides have communicated repeatedly many times.
Despite this, there were still some small "episodes" in the acceptance stage before the equipment entered the site ". There is a gap between the inlet and outlet of the equipment and the previous requirements, which will cause waste of raw materials. But because the construction period is very tight, the time nodes of each link are very close, if you can not enter the site on time, the whole project will be affected. This can be anxious for the project team. After communication and arrangement, it was finally decided to give the equipment manufacturer a week to revise it. After meeting the required requirements, the equipment was pulled over quickly. Other minor problems can only be to let the equipment manufacturer personnel come over and make on-site modifications.
In the trial production stage, in order to save costs, Qiubin Factory decided that the batch of products is 100 kg, while the design capacity of the equipment is 500 kg. There is no data that can be directly referred to for the process parameters such as ball mill speed, ball milling time and ball quantity. Before the trial, the members of the project team also consulted relevant production enterprises, however, the other party has only tried batch 300 kg, and has not succeeded. There are more than ten kinds of trial production schemes involved in the three parameters. Time and cost are not allowed to try multiple schemes. We can only rely on the collection and selection of indirect experience collected by project team members from various channels, and finally confirm the formation of the scheme decided to put into production. The trial production was an unexpected success. All the indexes of the three batches of trial production products passed the test. Moreover, the color, the most difficult index to control for artificial bezoar, was highly recognized by the sales agent.
The implementation of the whole project is relatively smooth, and there may be elements of luck, but behind this "luck", only the participants know how much effort and hardship they have put in. Cleaning the workshop equipment happens to be the hottest time. The weather has been more than 40 degrees for more than half a month, which makes the project team members unable to bear it. The workshop that has just been renovated is very dusty, but in order to ensure the cleaning quality, the air conditioner cannot be turned on, so it can only be cleaned under high temperature. Once out of the workshop, the whole person seems to have been soaked in water, and none of his body is dry. Moreover, his body is covered with dust. If there is something to do in the production workshop, he has to change clothes first.
Yan Xixia was impressed by one thing. The proportion and amount of balls in the ball mill will directly affect the product quality. For this reason, the two employees put 4 alumina balls of different sizes, totaling 2 tons, into small baskets one by one, and poured them into the ball mill with their bare hands for testing. The ball mill is large in size, and the feed port is above the machine. Employees holding the ball have to walk on a platform more than two meters high before they can pour in. If the ratio is not right, it has to be poured out again, cleaned, dried, and then poured in baskets again. This data alone has been tried for 3. four days. It goes up and down dozens of times a day. It is completely a physical job. Sometimes my hands shake after work. And sometimes afraid of miscounting the number of balls, employees squat down directly one by one.
Not only that, during the entire construction period from 4 to 7 February, Yu Chengfeng, Fang Weiming and Tang Songnian did not rest for a day and gave up their holidays. As long as the construction unit was present, they would have to be there. Finally, even the number of overtime days was not counted.
The end of the three batches of trial production products does not mean the end of this technological transformation project. They have a more important task, that is, to apply for GMP certification, and are now preparing for relevant materials. (Reporter Ni Yingzhen)
More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page